SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Solomon D,Schiffman M,Tarone R, for the ALTS Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001; 93: 293299.
  • 2
    Manos MM,Kinney WK,Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999; 281: 16051610.
  • 3
    Wright TCJr,Cox JT,Massad LS,Twiggs LB,Wilkinson EJ, for the 2001 ASCCP-Sponsored Consensus Conference. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002; 287: 21202129.
  • 4
    Flynn K,Rimm DL. Diagnosis of “ASCUS” in women over age 50 is less likely to be associated with dysplasia. Diagn Cytopathol. 2001; 24: 132136.
  • 5
    Kaminski PF,Sorosky JL,Wheelock JB,Stevens CWJr. The significance of atypical cervical cytology in an older population. Obstet Gynecol. 1989; 73: 1315.
  • 6
    Sherman ME,Schiffman M,Cox JT, for the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst. 2002; 94: 102107.
  • 7
    Clavel C,Masure M,Bory JP, et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer. 1999; 80: 13061311.
  • 8
    Cuzick J,Beverley E,Ho L, et al. HPV testing in primary screening of older women. Br J Cancer. 1999; 81: 554558.